Workflow
Buying the Best Value Stocks as the Market Hits All-Time Highs
ZACKS· 2025-08-12 21:36
Market Overview - The Nasdaq and the S&P 500 reached new highs as Wall Street anticipates interest rate cuts following a cooler-than-expected July inflation report [1] - Total earnings for S&P 500 companies that have reported are up 11.6% year-over-year with a revenue growth of 5.9%, indicating a potential all-time quarterly record for aggregate S&P 500 earnings [1] Q3 Outlook - The outlook for Q3 and beyond has improved significantly after strong second-quarter results from major tech companies [2] - Investors are encouraged to seek stocks that combine impressive value with improving earnings outlooks despite the surge in tech stock prices [2] Value Stock Screening - A value-focused screening method is employed to identify top value stocks, utilizing Zacks Rank 1 (Strong Buys) or 2 (Buys) [3][4] - The screening criteria include P/E ratios under the industry median and P/S ratios under the industry median to ensure relative value [4][8] SSR Mining Inc. (SSRM) Highlights - SSR Mining Inc. is highlighted as a top stock, with projected adjusted earnings growth of nearly 400% in 2025 and 53% next year [7][10] - The company reported a significant increase in Q2 results, with gold-equivalent production rising from 76,000 to 120,000 and revenue soaring 119%, leading to adjusted earnings of $0.51 per share, exceeding estimates by 122% [9] - SSRM's consensus earnings estimate has surged by 21% for FY25 and 13% for the following year, earning it a Zacks Rank 1 (Strong Buy) [10] Stock Performance and Valuation - SSR Mining's stock has increased by 1,100% over the past 25 years, outperforming its sector and the S&P 500 [11] - Despite this growth, SSRM is trading 60% below its 2007 peaks and is currently at a low price-to-earnings-to-growth (PEG) ratio of 0.4, indicating significant value [11] - On a forward earnings basis, SSRM trades at a 50% discount to its sector and 83% below its five-year highs [12]
Quest Resource: Price Has Become More Logical, But Still Unattractive Given Risks
Seeking Alpha· 2025-08-12 21:35
Core Insights - The stock price of the company has experienced a significant decline, falling nearly 80% since the last analysis, with a drop of 20-30% on the first day after the results were announced [1]. Group 1: Investment Philosophy - The investment approach focuses on operational aspects and long-term earnings potential rather than market-driven dynamics [1]. - The strategy emphasizes holding companies for the long term, with most recommendations being holds rather than buys [1]. - The analysis aims to provide valuable information for future investors and introduce skepticism in a generally bullish market [1].
Why Oklo Stock Jumped 9.2% Today
The Motley Fool· 2025-08-12 21:33
Oklo stock was down and then up in a day marked by significant volatility.Shares of Oklo (OKLO 9.49%) jumped on Tuesday, finishing the day up 9.2%. The spike came as the S&P 500 and Nasdaq Composite gained 1.1% and 1.3%, respectively.Oklo stock started the day down, having dropped in aftermarket trading following Monday's release of its latest quarterly earnings. However, news that the Department of Energy (DOE) has tapped the nuclear energy start-up for a key federal program led to a sharp reversal and the ...
Resolutions Adopted by the 2025 General Extraordinary Shareholders' Meeting
Prnewswire· 2025-08-12 21:30
MEXICO CITY, Aug. 12, 2025 /PRNewswire/ -- Grupo Rotoplas, S.A.B. de C.V. (BMV: AGUA*) ("Rotoplas" or "The Company"), leader in water management solutions in the Americas, informs the investing public about the proposals approved at the Extraordinary General Shareholders' Meeting held today, August 12th, 2025, at 10:00 am in Mexico City. Capital reimbursement to the Company's shareholders through a reduction of share capital.A capital reimbursement in cash to the Company's shareholders through a capital red ...
Medexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX (treosulfan) for Injection
Newsfile· 2025-08-12 21:30
Medexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX (treosulfan) for InjectionAugust 12, 2025 5:30 PM EDT | Source: Medexus Pharmaceuticals Inc.Fiscal Q1 2026 net revenue of $24.6 million, net income of $0.5 million, operating income of $0.9 million, and Adjusted EBITDA* of $3.4 million$3.0 million of product-level net revenue from GRAFAPEX in fiscal Q1 2026, relative to $3.0 million of personnel and infrastructure investments, further supporting Med ...
Autodesk launches freemium access to Autodesk Flow Studio, with new pricing tiers making world-class VFX AI more affordable to all creators
Prnewswire· 2025-08-12 21:30
For the first time, Autodesk is offering free access to professional grade AI-powered VFX and animation tools — removing cost barriers for indie filmmakers, digital content creators, marketers, and first-time users around the worldSAN FRANCISCO, Aug. 12, 2025 /PRNewswire/ -- Today at SIGGRAPH 2025, Autodesk, Inc. (NASDAQ: ADSK) launched new, more affordable pricing for Autodesk Flow Studio (formerly Wonder Studio) including its first free tier and a 50% price drop for the Lite plan – from $20 to $10 – a sig ...
If Qualcomm Holds $145, Its Next Move Could Be Massive
MarketBeat· 2025-08-12 21:28
QUALCOMM TodayQCOMQUALCOMM$153.73 +5.76 (+3.89%) 52-Week Range$120.80▼$182.10Dividend Yield2.32%P/E Ratio14.82Price Target$181.10Add to WatchlistTech giant Qualcomm Inc. NASDAQ: QCOM has once again been testing the patience of even its most loyal investors. Despite consistently beating earnings expectations, operating in one of the market's hottest sectors, and trading against the backdrop of record-high equity indices, the stock still can’t break free. It’s now down 3% for the year, while the S&P 500 has ...
Autolus Therapeutics: Expanding The Reach Of Its CD19 Therapy, But Still Far From Profitable
Seeking Alpha· 2025-08-12 21:26
I'm one of what feels like a handful of people willing to put positive opinions on cell therapy companies, and I'm on record as having bullish sentiment on Autolus Therapeutics (NASDAQ: AUTL ). When last II have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investin ...
Why Franco-Nevada Stock Crawled Higher Today
The Motley Fool· 2025-08-12 21:22
A pair of mildly bullish analyst moves pushed the gold stock higher.Gold streaming and royalty company Franco-Nevada's (FNV 1.16%) stock had a bit of luster on the second trading day of the week. Its shares closed Tuesday up by almost 1.3% on a pair of analyst price-target hikes following the company's latest earnings release. That little pop was sufficient to edge past the S&P 500 index, which closed 1.1% higher. Not one but two price-target bumpsNot one but two pundits following Franco-Nevada upped their ...
CTO Shareholder Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against CTO Realty Growth, Inc.
GlobeNewswire News Room· 2025-08-12 21:19
SAN DIEGO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired CTO Realty Growth, Inc. (NYSE: CTO) securities between February 18, 2021 and June 24, 2025. CTO is a publicly traded real estate investment trust ("REIT") that owns and operates a portfolio of purported high-quality, retail-based properties located primarily in higher growth markets in the U.S. For more information, submit a form, email attorn ...